Collaborators |
Detail Information
Publications
An open trial of reboxetine in HIV-seropositive outpatients with major depressive disorderAdriana S Carvalhal
Department of Psychiatry, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil
J Clin Psychiatry 64:421-4. 2003..Reboxetine is a noradrenergic antidepressant that is not metabolized by CYP450 and may offer a valuable option in the treatment of MDD in HIV-seropositive patients...
